Donanemab for Treatment of Alzheimer Disease | NeurologyLive - Clinical Neurology News and Neurology Expert Insights
Donanemab for Treatment of Alzheimer Disease | NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1 year ago
neurologylive.com
📍 Day 3 at #AAIC2025 in #Toronto. What we're looking into today? The role of #technology in #Alzheimers #research. 🩻 🧠 🖥️ From new #PET scanning methods to the use of #AI to analyze large #data sets, these tools are used to transform the entire ecosystem — from identifying patients to developing #treatments and searching for a cure. 🔗 Watch this space for more live coverage from #AAIC: https://beingpatient.com/tag/aaic/?utm_source=organic&utm_medium=social 🔗#Alzheimers #BrainHealth #Dement
0:41
📍 Day 3 at #AAIC2025 in #Toronto. What we're looking into today? The role of #technology in #Alzheimers #research. 🩻 🧠 🖥️ From new #PET scanning methods to the use of #AI to analyze large #data sets, these tools are used to transform the entire ecosystem — from identifying patients to developing #treatments and searching for a cure. 🔗 Watch this space for more live coverage from #AAIC: https://beingpatient.com/tag/aaic/?utm_source=organic&utm_medium=social 🔗#Alzheimers #BrainHealth #Dement
119 views9 months ago
FacebookBeing Patient Alzheimer's
Biomed Industries Presents Four Breakthrough Studies on Alzheimer’s, Rett Syndrome, and Obesity Therapies at AAIC 2025
Biomed Industries Presents Four Breakthrough Studies on Alzheimer’s, Rett Syndrome, and Obesity Therapies at AAIC 2025
9 months ago
einpresswire.com
New Alzheimer’s Drugs 2025 | Donanemab & Lecanemab Results Explained
0:31
New Alzheimer’s Drugs 2025 | Donanemab & Lecanemab Results Explained
107 views6 months ago
YouTubeRe:Cognition Health
Durante o AAIC 2025, a maior conferências do mundo sobre Alzheimer e outras demências, nossa diretora pedagógica, Patricia Lessa, conversou com a Profa. Dra. Mônica Yassuda, uma das responsáveis pelo Estudo Supera de Estimulação Cognitiva. Na conversa, elas comentam sobre a importância de apresentar esse estudo em um congresso de alcance global, que reúne especialistas, cientistas e profissionais de referência na área da saúde cerebral. Assista agora! #Supera #AAIC2025 #ConferenciaInternacional
1:44
Durante o AAIC 2025, a maior conferências do mundo sobre Alzheimer e outras demências, nossa diretora pedagógica, Patricia Lessa, conversou com a Profa. Dra. Mônica Yassuda, uma das responsáveis pelo Estudo Supera de Estimulação Cognitiva. Na conversa, elas comentam sobre a importância de apresentar esse estudo em um congresso de alcance global, que reúne especialistas, cientistas e profissionais de referência na área da saúde cerebral. Assista agora! #Supera #AAIC2025 #ConferenciaInternacional
696 views9 months ago
FacebookMétodo Supera
Today an FDA advisory panel is meeting to discuss donanemab for the treatment of Alzheimer disease. JAMA published the results of the TRAILBLAZER-ALZ 2 trial which found that donanemab treatment significantly slowed clinical progression at 76 weeks. Read the study: https://ja.ma/3X7Q2Rs | JAMA
0:59
Today an FDA advisory panel is meeting to discuss donanemab for the treatment of Alzheimer disease. JAMA published the results of the TRAILBLAZER-ALZ 2 trial which found that donanemab treatment significantly slowed clinical progression at 76 weeks. Read the study: https://ja.ma/3X7Q2Rs | JAMA
513 viewsJun 10, 2024
FacebookJAMA
Ecco all'AAIC i risultati dello studio di fase III su donanemab
Ecco all'AAIC i risultati dello studio di fase III su donanemab
Aug 2, 2023
Il Sole 24 ORE
Understanding Donanemab: The Alzheimer's Drug That's Making Waves
May 25, 2024
usc.edu
FDA advisers strongly back new Alzheimer’s drug, despite risks and limitations
Jun 10, 2024
npr.org
Eisai: Early Alzheimer's Patients Continue to Benefit from Four Years of LEQEMBI(R) (lecanemab-irmb) Therapy New Clinical Data Presented at AAIC
9 months ago
finanznachrichten.de
3:06
🧠 At #AAIC2025, Being Patient founder Deborah Kan tried Hyperfine, Inc.'s Swoop system — a portable #MRI that makes hashtag#brain scans possible almost anywhere. ⚡ In just 6 minutes on the conference floor in Toronto, Deborah experienced what Edmond Knopp, MD and Maria Sanis described as an “ultra low field” MRI. Unlike conventional scans, there’s no need to remove metal, no expensive facility build‑out, and it runs on a simple 15‑amp plug. 🔍 The team demonstrated how the system produces image
272 views9 months ago
FacebookBeing Patient Alzheimer's
4:26
Donanemab approved in Australia for treatment of Alzheimer's disease
1 year ago
ABC Newsthe Specialist Reporting Team's Paige Cockburn
3:05
Patients who received donanemab demonstrated a 35% slower decline in memory, thinking and their ability to perform daily activities, according to clinical trial data from its maker, Eli Lilly. https://cnb.cx/3HCNT7A | CNBC
1.6K viewsMay 3, 2023
FacebookCNBC
54:14
U.S. POINTER Study Results Press Briefing | AAIC 2025
1.9K views9 months ago
YouTubeAlzheimer's Association
AAIC 2025: US POINTER Study Shows Lifestyle Interventions Can Turn Back Cognitive Clock by 1-2 Years
9 months ago
substack.com
Abstract Submission | AAIC | Alzheimer's Association
Mar 25, 2022
alz.org
2:14
Promising Alzheimer's drug Donanemab offers hope for millions, awaits FDA approval
Jul 17, 2023
wjla.com
2:22
There’s more mixed news on another Alzheimer’s disease drug. Donanemab is the second drug this year to be approved by the MHRA as a safe and effective treatment for early Alzheimer’s disease. This is another milestone. However, draft guidance from NICE which considers both the benefits and costs of the drugs, did not recommend donanemab be provided on the NHS. We know this is disappointing, but research will beat dementia. There are around 20 disease modifying treatments in late-stage trials for
2.4K viewsOct 23, 2024
FacebookAlzheimer's Society
AAIC For All: Clinicians | Alzheimer's Association
Mar 11, 2025
alz.org
3:48
Donanemab For Alzheimer’s: Mechanism of Action & Key Clinical Study Results Explained│ Pharmacology
2.5K viewsJul 2, 2024
YouTubePharmacology Insights
Conference Highlights | AAIC 2024 | Alzheimer's Association
Aug 1, 2024
alz.org
1:48:39
Advances in Alzheimer's Disease Research: AAIC 2025
1K views8 months ago
YouTubeMichigan Medicine
New Alzheimer's treatment shows promising clinical results
Jul 21, 2023
enca.com
30:45
Alzheimer's (MCI) Presentation | Vielight | Dr. Lew Lim and Dr. Neda Rashidi | AAIC 2025
756 views9 months ago
YouTubeVielight Inc
1:23
Reshaping the Fight Against Alzheimer's: The Donanemab Revolution
1.2K viewsMay 27, 2023
YouTubeThe Brain Docs
1:30:12
A New Era: Understanding Lecanemab, Donameb, and Emerging Therapies for Alzheimer's Disease
1.5K viewsNov 9, 2023
YouTubeUMNCHAI
35:48
Optimizing Outcomes With ATTs in Alzheimer’s Disease: Clinical Pearls From AAIC 2025
111 views8 months ago
YouTubePeerView CME
17:10
Episode 146: Overviewing Donanemab’s New Dosing Regimen: Lowering ARIA Risk in Alzheimer Care
167 views9 months ago
YouTubeNeurologyLive
1:06:18
Plenary Perspectives: What We Learned at AAIC 2025
231 views8 months ago
YouTubeDementia Researcher
0:08
🏋🏼‍♂️ on Instagram: "☠️just focus ❤️‍🔥⚡️📈 #banglore #reels #motivation #explorepage #exploringnewideas #reelsinstagram #contentcreator #aestheticbuild #reelkarofeelkaro #reelitfeelit #trendingreels #growwithme #reachmorepeople #explorepage*+ #viralreels #getfit #gymrat #ironbuilt #motivationalvideos #motivational #reelsinstagram #instaviews #instareach #viral#instalike#kannad #kannada #reels #newreels❤️"
3.8K views5 months ago
Instagram_sethu.54
See more